These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2073 related items for PubMed ID: 18977269

  • 1. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.
    Vaccine; 2009 Jan 01; 27(1):28-37. PubMed ID: 18977269
    [Abstract] [Full Text] [Related]

  • 2. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y, Wang B, Hu L, Yu H, Da Z, Jiang W, Song N, Qie Y, Wang H, Tang Z, Xian Q, Zhang Y, Zhu B.
    Vaccine; 2009 Oct 19; 27(44):6179-85. PubMed ID: 19712772
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W, Ohara N, Yamada T, Kinoshita T, Yoshikai Y.
    J Infect Dis; 2008 May 01; 197(9):1263-74. PubMed ID: 18422438
    [Abstract] [Full Text] [Related]

  • 4. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
    Xu Y, Zhu B, Wang Q, Chen J, Qie Y, Wang J, Wang H, Wang B, Wang H.
    FEMS Immunol Med Microbiol; 2007 Dec 01; 51(3):480-7. PubMed ID: 17919299
    [Abstract] [Full Text] [Related]

  • 5. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S, Gong Q, Wang C, Liu H, Wang Y, Guo S, Wang W, Liu J, Shao M, Chi L, Zhao K, Wang Z, Shi Y, Huang Y, Guli A, Zhang C, Kong X.
    Immunol Lett; 2008 May 15; 117(2):136-45. PubMed ID: 18339431
    [Abstract] [Full Text] [Related]

  • 6. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
    Bennekov T, Dietrich J, Rosenkrands I, Stryhn A, Doherty TM, Andersen P.
    Eur J Immunol; 2006 Dec 15; 36(12):3346-55. PubMed ID: 17109467
    [Abstract] [Full Text] [Related]

  • 7. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.
    Andersen CS, Dietrich J, Agger EM, Lycke NY, Lövgren K, Andersen P.
    Infect Immun; 2007 Jan 15; 75(1):408-16. PubMed ID: 17074845
    [Abstract] [Full Text] [Related]

  • 8. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, Palfliet K, Huygen K.
    Vaccine; 2006 Apr 12; 24(16):3353-64. PubMed ID: 16488518
    [Abstract] [Full Text] [Related]

  • 9. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
    Luo Y, Jiang W, Da Z, Wang B, Hu L, Zhang Y, An R, Yu H, Sun H, Tang K, Tang Z, Wang Y, Jing T, Zhu B.
    Scand J Immunol; 2012 Mar 12; 75(3):293-300. PubMed ID: 22117839
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q, Yu H, Zhang Y, Wang B, Jiang W, Da Z, Xian Q, Wang Y, Liu X, Zhu B.
    Scand J Immunol; 2011 Jun 12; 73(6):568-76. PubMed ID: 21323695
    [Abstract] [Full Text] [Related]

  • 11. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL.
    Vaccine; 2009 Nov 12; 27(48):6712-22. PubMed ID: 19733584
    [Abstract] [Full Text] [Related]

  • 12. Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs.
    Dey B, Jain R, Khera A, Rao V, Dhar N, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK.
    Vaccine; 2009 Dec 10; 28(1):63-70. PubMed ID: 19835824
    [Abstract] [Full Text] [Related]

  • 13. Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers.
    van Dissel JT, Arend SM, Prins C, Bang P, Tingskov PN, Lingnau K, Nouta J, Klein MR, Rosenkrands I, Ottenhoff TH, Kromann I, Doherty TM, Andersen P.
    Vaccine; 2010 Apr 30; 28(20):3571-81. PubMed ID: 20226890
    [Abstract] [Full Text] [Related]

  • 14. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
    Dou J, Tang Q, Yu F, Yang H, Zhao F, Xu W, Wang J, Hu W, Hu K, Liou C, Feng He X, Wang Y.
    Immunobiology; 2010 Apr 30; 215(2):133-42. PubMed ID: 19450898
    [Abstract] [Full Text] [Related]

  • 15. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 30; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 16. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L, Cassone A.
    Cell Microbiol; 2007 Jun 30; 9(6):1455-65. PubMed ID: 17250590
    [Abstract] [Full Text] [Related]

  • 17. Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A.
    Gartner T, Baeten M, Otieno S, Revets H, De Baetselier P, Huygen K.
    Immunol Lett; 2007 Jul 31; 111(1):26-35. PubMed ID: 17570535
    [Abstract] [Full Text] [Related]

  • 18. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
    Dou J, Wang Y, Yu F, Yang H, Wang J, He X, Xu W, Chen J, Hu K.
    Int J Immunogenet; 2012 Apr 31; 39(2):183-90. PubMed ID: 22152009
    [Abstract] [Full Text] [Related]

  • 19. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, Bauche C, Nouzé C, Ladant D, Cole ST, Sebo P, Leclerc C.
    Infect Immun; 2006 Apr 31; 74(4):2128-37. PubMed ID: 16552042
    [Abstract] [Full Text] [Related]

  • 20. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
    Fan X, Gao Q, Fu R.
    Scand J Immunol; 2007 Nov 31; 66(5):523-8. PubMed ID: 17916110
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 104.